roflumilast

April 7, 2016April 7, 2016

Study of Roflumilast for COPD Confirms Benefits as Alternative Therapy

COPD, News

Researchers at Sichuan University in China conducted a study to clarify the controversial therapeutic effects of roflumilast in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD). The team found that roflumilast led ... Read more

September 7, 2015November 6, 2015

Roflumilast Reduces Airway Inflammation in Asthma Patients

Asthma, News

In a new study entitled “Roflumilast for asthma: Efficacy findings in mechanism of action studies,” researchers evaluated the potential therapeutic effects of roflumilast, a treatment used in patients with severe chronic ... Read more

March 26, 2015November 9, 2015

Mechanism Underlying Tolerance to COPD Therapeutic Drug Revealed

COPD, News

A team led by researchers at Georgia State University in Atlanta recently revealed a previously unknown mechanism behind the development of tolerance to the drug roflumilast used in the treatment ... Read more

May 26, 2014November 11, 2015

Forest Laboratories, Inc. Presents Data of COPD Therapy Aclidinium, Aclidinium/Formoterol Combination, and Roflumilast

COPD, News

Forest Laboratories, Inc., a New York-based pharmaceutical company, announced that it will present data on TUDORZA PRESSAIR (aclidinium bromide inhalation powder), a combination use of aclidinium bromide/formoterol fumarate, and DALIRESP ... Read more